Back to search results

Mobile Health Strategies for Postpartum Hypertension

This study is testing two different mobile health (mHealth) strategies to help manage high blood pressure (hypertension) after pregnancy. You might be able to join if you are a woman aged 18 or older, delivered within the last 14 days, and were diagnosed with preeclampsia or gestational hypertension. You also need to have started blood pressure medication and be able to text in English or Spanish. The study is comparing "High-touch blood pressure management" (12 weeks of text-based home blood pressure monitoring with self-management and team care) and "Low-touch blood pressure management" (10 days of text-based home blood pressure monitoring). Researchers want to see if these strategies improve your blood pressure and heart function, and help you feel more in control of your health. The main goal is to measure your diastolic blood pressure (the bottom number) 12 months after you give birth. The study plans to enroll 770 participants, but its current recruitment status is unclear.

Study design
This is a multicenter randomized trial, meaning participants are randomly assigned to one of two groups. It plans to enroll 770 women.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your diastolic blood pressure will be measured 12 months postpartum.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07209254

Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

Recruiting
NAAges 18+InterventionalTreatment
Jennifer Lewey, MD, MPH
~770 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:High-touch blood pressure managementLow-touch blood pressure management

At a glance

Recruiting sites
2 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean diastolic blood pressure (DBP)
Measured over 12 months postpartum

Conditions

Hypertension, Pregnancy Induced

Explore related trials

Gestational HypertensionPreeclampsia

Where it's being run

3 sites across 3 states
New York1
Ohio1
Pennsylvania1

Study leadership

  • Jennifer Lewey, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

Jennifer Lewey, MD, MPH
[email protected]
215-662-7700
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥18 years
Delivery within 14 days
Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum
Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum
English or Spanish speaking (able to read/understand consent and instructions)
Has phone texting capabilities

Exclusion

Diagnosis of chronic hypertension prior to delivery (would therefore include super imposed preeclampsia)
Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced ejection fraction, ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery)
Chronic kidney disease (stage 3 or higher)
Using ≥3 BP medications at time of enrollment

What this trial measures

  • Mean diastolic blood pressure (DBP)12 months postpartum

    Assessed by 24-hour ambulatory blood pressure monitor (ABPM)